Simplex Trading’s Eterna Therapeutics ERNA Stock Holding History

Simplex Trading’s Portfolio ERNA Stock Details ERNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1	Closed	-$11K	–	9479
2022 Q3	$11K	Hold	1	–	–	﹤0.01%	8133
2022 Q2	$2K	Hold	1	–	–	﹤0.01%	9333
2022 Q1	$12K	Hold	1	–	–	﹤0.01%	8728
2021 Q4	$38K	Sell	1 -7	-88%	-$381K	﹤0.01%	7593
2021 Q3	$968K	Buy	8 +1	+14%	+$86.3K	﹤0.01%	3120
2021 Q2	$1.01M	Buy	+7	New	+$1.01M	﹤0.01%	3102

Other funds holding ERNA

Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return

CPWM

Cypress Point Wealth Management Dallas, Texas $492M AUM 22.57% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Simplex Trading's ERNA Position: Q3 2022 in Review

Simplex Trading sold out of Eterna Therapeutics (ERNA) in Q3 2022, closing a stake of 1 share — an estimated $3.45K sold.

Simplex Trading first reported a position in ERNA in Q2 2021 and held it in 4 quarters. The position peaked at $480K in Q2 2021. 31 funds tracked by Wall St. Rank hold ERNA as of Q3 2022.

Simplex Trading reported no remaining Eterna Therapeutics position as of Q3 2022 after selling out during the quarter.
Simplex Trading sold 1 Eterna Therapeutics share in Q3 2022, an estimated $3.45K.
Simplex Trading first reported a position in Eterna Therapeutics in Q2 2021 and held it in 4 quarters.
Simplex Trading's Eterna Therapeutics position peaked at $480K in Q2 2021.
31 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.